AstraZeneca's revenues will see virtually no growth in 2009, and the company has extended its cost cutting programme. Chief executive …
Roche will shed 780 production jobs over the next two years as it continues to streamline its manufacturing operations, but …
Bristol Myers Squibb has denied claims it is making a further 10% reduction to its work force, and said any …
Pfizer is to cut its workforce in France by axeing 700 jobs in order to reduce costs and counteract patent …
Lilly aims to reduce the cost of it bringing new molecules to market by a third.The company's goal is to …
Sanofi-Aventis' head of finance and legal affairs Jean-Claude Leroy is to leave the company as new chief executive Chris Viehbacher …
GlaxoSmithKline is set to cut about 850 jobs in early-stage research and development at sites across the world, including the …
A simplified and slimmed-down corporate structure has been unveiled by US pharmaceutical firm Lilly, which says it hopes to cut …
GlaxoSmithKline has unveiled new appointments to its board of directors and the departure of its current president of Pharmaceuticals David …